Head-to-head · WeighScore
Framework vs Sunlight.com
The verdict
Sunlight.com takes it — 85.4/100 to 51.6/100.
Sunlight.com grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the cheapest published rates in the ranking — semaglutide $88/mo, tirzepatide $157/mo, flat and stated never to rise — from a LegitScript-certified telehealth with two named, NPI-verified physicians.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Framework | Sunlight.com |
|---|---|---|
| WeighScore | 51.6/100 | 85.4/100 |
| Grade | C | B |
| Scorecard rank | #494 | #7 |
| Semaglutide | Not disclosed | $88/mo |
| Tirzepatide | Not disclosed | $157/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #494 · C
Strengths
- The compounding pharmacy partner is named, which most of this field does not do
- Treatment selection is doctor-guided rather than a fixed product menu
- US-licensed clinicians and a 503A pharmacy pathway
Where it loses points
- No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
- The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
- A '$75/month with 3-month package' figure is footnoted as a promotion for new GLP-1 users only
- Different landing pages advertise different per-week rates, $25 on one and $19 on another
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #7 · B
Strengths
- Cheapest published semaglutide in this ranking ($88/mo) with competitively priced tirzepatide ($157/mo), both flat and stated to never increase — not quiz-gated, the FAQ states the exact figures
- LegitScript-certified with two named physicians and public NPI numbers (Lion MD network), rather than an anonymous "licensed clinicians" claim
- No membership fee, cancel anytime, free shipping in 1-2 days, a fresh 4-week supply every month
- All 50 states served, plus a separate live NAD+ program on the same domain
Where it loses points
- Injection only — the hero banner's "Injections and oral options available" line does not match the live site: no oral GLP-1 product page exists and sunlight.com/oral-semaglutide/ 404s
- The $157 tirzepatide figure sits inside a collapsed FAQ accordion rather than the hero, so it takes one extra click to find even though it is genuinely on the page
- Sermorelin is marketed as "launching soon" and is not yet live — do not expect it today
- No published lab or monitoring cadence, and the compounding pharmacy partner is referenced only generically, not named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 509 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.